[BMP1 fusion protein expressed in E. coli]

Area of Science:

• Molecular Biology
• Biochemistry
• Recombinant DNA Technology

Background:

• Bone Morphogenetic Proteins (BMPs) are crucial for bone formation and regeneration.
• Efficient production of functional BMPs is essential for therapeutic development.
• Recombinant DNA techniques offer a powerful tool for protein expression and purification.

Purpose of the Study:

• To construct and express a recombinant plasmid encoding a BMP1 fusion protein.
• To confirm the identity and purity of the expressed BMP1 fusion protein.
• To generate specific antibodies against the BMP1 fusion protein for further validation.

Main Methods:

• Recombinant DNA technology was employed to construct the pMS32C/BMP1 expression plasmid.
• High-level expression of the 66 kDa BMP1 fusion protein in E. coli.
• Purification of the fusion protein using SDS-PAGE.
• Generation of specific antiserum in mice via immunization with the fusion protein.
• Immunoprecipitation and immuno-dot assays to confirm antibody specificity and protein binding.

Main Results:

• Successful construction and validation of the pMS32C/BMP1 plasmid.
• High-level expression of the 66 kDa BMP1 fusion protein, constituting 20% of total bacterial proteins.
• Purified BMP1 fusion protein yielded specific antisera with high titers.
• Antisera demonstrated specific binding to purified human bone BMPs, confirming the human BMP moiety.

Conclusions:

• The constructed plasmid successfully directs the expression of a 66 kDa BMP1 fusion protein.
• The expressed BMP1 fusion protein is highly pure and contains the human BMP moiety.
• The generated antiserum is specific and can be used for further studies involving human BMPs.